These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11504772)

  • 21. A population-based study of colorectal cancer histology in the United States, 1998-2001.
    Stewart SL; Wike JM; Kato I; Lewis DR; Michaud F
    Cancer; 2006 Sep; 107(5 Suppl):1128-41. PubMed ID: 16802325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data.
    Liu Z; Zhang Y; Franzin L; Cormier JN; Chan W; Xu H; Du XL
    Int J Oncol; 2015 Apr; 46(4):1819-26. PubMed ID: 25672365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second primary malignancies in adult acute myeloid leukemia--A US population-based study.
    Ghimire KB; Shah BK
    Anticancer Res; 2014 Jul; 34(7):3855-9. PubMed ID: 24982414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second primary malignancies and survival of adult patients with polycythemia vera: A United States population-based retrospective study.
    Khanal N; Giri S; Upadhyay S; Shostrom VK; Pathak R; Bhatt VR
    Leuk Lymphoma; 2016; 57(1):129-33. PubMed ID: 26159045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Khanal A; Budhathoki N; Singh VP; Shah BK
    Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of secondary primary malignancy in early stage differentiated thyroid cancer: a US population-based study.
    Uprety D; Khanal A; Arjyal L; Bista A; Basnet B; Kandel P; Gogireddy TR; Adhikari J
    Acta Oncol; 2016 Nov; 55(11):1375-1377. PubMed ID: 27579851
    [No Abstract]   [Full Text] [Related]  

  • 27. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.
    Erenay FS; Alagoz O; Banerjee R; Said A; Cima RR
    Cancer; 2016 Aug; 122(16):2560-70. PubMed ID: 27248907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden?
    Murphy CC; Lund JL; Sandler RS
    Gastroenterology; 2017 Jun; 152(8):1809-1812.e3. PubMed ID: 28461196
    [No Abstract]   [Full Text] [Related]  

  • 32. Invited commentary.
    Wexner SD; Boutros M
    J Am Coll Surg; 2011 Sep; 213(3):361-2. PubMed ID: 21871382
    [No Abstract]   [Full Text] [Related]  

  • 33. Age-specific incidence of all neoplasms after colorectal cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Ann Epidemiol; 2014 Oct; 24(10):785-8. PubMed ID: 25169681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005.
    Cheng L; Eng C; Nieman LZ; Kapadia AS; Du XL
    Am J Clin Oncol; 2011 Dec; 34(6):573-80. PubMed ID: 21217399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High constant incidence of second primary colorectal cancer.
    Levi F; Randimbison L; Blanc-Moya R; Maspoli-Conconi M; Rosato V; Bosetti C; La Vecchia C
    Int J Cancer; 2013 Apr; 132(7):1679-82. PubMed ID: 22903312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High constant incidence rates of second primary neoplasms.
    Levi F; Boffetta P; La Vecchia C
    Eur J Cancer Prev; 2008 Oct; 17(5):385-8. PubMed ID: 18714177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
    Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
    Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secular changes in NSAID use and invasive colorectal cancer incidence: an ecological study.
    Lamont EB; Dias LE
    Cancer J; 2008; 14(4):276-7. PubMed ID: 18677138
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.